TNFRSF9 Recombinant Protein
Applications:- Enzyme-Linked Immunosorbent Assay (ELISA)
- Western Blot (WB)
Storage:
Lyophilized Protein should be stored at -20°C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20°C or -70°C. Avoid repeated freeze-thaw cycles.
No additional charges, what you see is what you pay! *
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available!
Contact us to find what you can save.
This product comes from:
United States.
Typical lead time:
14-21 working days.
Contact us for more accurate information.
- Further Information
- Documents
- Show All
Further Information
TNFRSF9, 4-1BB, CD137, CDw137, ILA
This recombinant protein can be used for WB. For research use only.
4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.
- Cooper D, et al., 2002, Eur. J. Immunol. 32 (2): 521?9.
- Jang, I K., et al., 1998, Biochem. Biophys. Res. Commun. (UNITED STATES) 242 (3): 613?20.
- Arch, R H., Thompson C B., 1998, Mol. Cell. Biol. (UNITED STATES) 18 (1): 558?65.
Measured by its binding ability in a functional ELISA. When Recombinant Human 4-1BB Protein, With C-Fc Tag is Immobilized at 10 ng/mL (100 μl/well), Recombinant Human 4-1BB Ligand produces 50% optimal binding response with a concentration range of 0. 75 ? 3. 0 ng/mL.
50 mM tris, 100 mM glycine, pH7.5.
C-Fc Tag
3604
tumor necrosis factor receptor superfamily, member 9
TNFRSF9
Homo sapiens
Lyophilized
Predicted Molecular Weight:
43.3 kDa
NP_001552.2
>95% as determined by SDS-PAGE.
Recombinant Protein Sequence:
Thr32-Gly402
HEK293 cells
Q07011
